Trials / Completed
CompletedNCT03473626
Phase 1 Food Effect Study for Alicaforsen Tablets
A Two-Period, Randomised, Crossover Study Designed to Evaluate the In Vivo Performance of a Modified Release Formulation of Alicaforsen in Healthy Male Subjects in the Fed and Fasted State
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Atlantic Pharmaceuticals Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Phase 1 study to compare the effect of food on alicaforsen tablet.
Detailed description
A study on healthy male vounteers in a phase 1 unit. Alicaforsen tablets are gievn in a fed and fasted state
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alicaforsen | Alicaforsen tablet |
Timeline
- Start date
- 2018-03-16
- Primary completion
- 2018-04-06
- Completion
- 2018-04-06
- First posted
- 2018-03-22
- Last updated
- 2018-11-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03473626. Inclusion in this directory is not an endorsement.